Release Date: 17/02/11 14:44 Summary: Response to ASX Price Query Price Sensitive: Yes Download Document 277.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%